February 21, 2014 Mr. Jiayue Zhang Chairman and President Shanxi Taxus Pharmaceuticals Co., Ltd. Houfangnan, Yutai Rd. Yuci District Jinzhong City, Shanxi Province China 030600Cardium Therapeutics, Inc. • March 4th, 2014 • Biological products, (no disgnostic substances)
This letter is to confirm the terms of a strategic cooperation between Cardium Therapeutics, Inc., on behalf of itself and its affiliates (individually and collectively “Cardium”) and Shanxi Taxus Pharmaceuticals Co., Ltd. on behalf of itself and its affiliates (individually and collectively “Taxus”), with such affiliates being those as defined in that certain Stock Purchase Agreement entered into as of February 21, 2014, by and between Cardium and Taxus (the “Stock Purchase Agreement”). The terms of this strategic cooperation shall be as set forth below, based on the reciprocal obligations of Cardium and Taxus as provided herein and in the Stock Purchase Agreement.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 4th, 2014 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Stock Purchase Agreement (this “Agreement”) is made and entered into as of February 21, 2014 (the “Effective Date”), by and between Cardium Therapeutics, Inc., a Delaware corporation (“Cardium” or the “Company”), and Shanxi Taxus Pharmaceuticals Co., Ltd., a limited liability company of the People’s Republic of China (“Taxus” or the “Purchaser”), with reference to the following facts:
